Recent CAR-T coverage in mainstream media (in reverse chronological order)…

I haven’t actually read these yet myself, but they are circulating among the social media.  I’m hoping to add some commentary after reading:

Experimental Cancer Treatment That Terminates Rogue Cells Could Arrive in 2017 – Seeker (2016/12/23)
http://www.seeker.com/a-biologic-assassin-car-t-cell-turns-immune-system-against-cancer-2161950283.html

2017 shaping up to be pivotal year for CAR-T and CRISPR therapies | FierceBiotech (2016/12/22)
http://www.fiercebiotech.com/biotech/2017-shaping-up-to-be-pivotal-year-for-car-t-and-crispr-therapies

Opinion: Balancing Risks and Rewards of CAR T-Cell Therapy | The Scientist Magazine® (2016/12/15)
http://www.the-scientist.com/?articles.view/articleNo/47788/title/Opinion–Balancing-Risks-and-Rewards-of-CAR-T-Cell-Therapy/

CAR T-Cell Therapy The Road Ahead (2016/08/11)
http://www.bioprocessonline.com/doc/car-t-cell-therapy-the-road-ahead-0001


I won’t pretend to understand the significance of this, but it is making the social media rounds, and seems to indicate just how competitive this CAR-T field is:

Juno Therapeutics Defeats Kite Pharma’s Challenge to CAR T-Cell Patent – 1stOncology™: Cancer Intelligence Service
http://www.1stoncology.com/blog/juno-therapeutics-defeats-kite-pharma-s-challenge-to-car-t-cell-patent/


A bit old (February 2016), but comprehensive, and it’s written by my CAR-T trial oncologist.  🙂

CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date | Blood Journal
http://www.bloodjournal.org/content/127/26/3312

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s